Replies to post #22141 on RespireRx Pharmaceuticals Inc (fka RSPI)

[davidal66]

erbse24448... this one still is enrolling for ADHD: http://www.clinicaltrials.gov/ct2/show/NCT00610441?intr=%22ORG+26576%22&rank=2

I'm not sure what happened to the depression trial. I think there was a third in-house SGP/Organon trial for depression which was of longer duration for the backup to ORG24448 which is now being tested in ADHD. I think the patent exp. date on this compound is 2017-2018.

ps... happy thanksgiving to all....